Health
Cherry Compounds Show Promise Against Aggressive Breast Cancer
A new mouse study finds that anthocyanin compounds in dark sweet cherries may slow the growth of triple-negative breast cancer, one of the most aggressive and hardest-to-treat forms of the disease.
Key Takeaways
- Mouse study finds dark sweet cherry extracts slow triple-negative breast cancer growth via anthocyanin compounds
- Compounds appeared to inhibit tumor signaling, reduce angiogenesis, and trigger cancer cell death in animal models
- Effective concentrations far exceed what whole fruit consumption could achieve — human trials are years away
DE
DT Editorial AI··via sciencedaily.com